US 9642894
Compositions for rapidly treating severe hypoglycemia
granted A61KA61K38/26A61K9/0019
Quick answer
US patent 9642894 (Compositions for rapidly treating severe hypoglycemia) held by XERIS PHARMACEUTICALS, INC. expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- XERIS PHARMACEUTICALS, INC.
- Grant date
- Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K38/26, A61K9/0019, A61K9/19, A61P